Veröffentlichungen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Besser, Daniel Dr. (1) Beule, Dieter Dr. (1) Birchmeier, Walter Prof. Dr. (1) Birchmeier-Kohler, Carmen Prof. Dr. (1) Blankenstein, Thomas Prof. Dr. (5) Blüthgen, Nils (1) Daniel, Peter Prof. Dr. (1) Daumke, Oliver Prof. Dr. (1) Dittmar, Gunnar Dr. (2) Höpken, Uta Elisabeth PD Dr. (1) Kammertöns, Thomas Dr. (3) Kieback, Elisa Dr. (1) Kobelt, Dennis Dr. (1) Leisegang, Matthias Dr. (1) Lusatis, Simone (1) Mathas, Stephan Dr. (11) Rehm, Armin Dr. (1) Scheidereit, Claus Prof. Dr. (1) Schlag, Peter M. Prof. Dr. (1) Selbach, Matthias Prof. Dr. (14) Uckert, Wolfgang Prof. Dr. (13) Willnow, Thomas Prof. Dr. (1) (-) Janz, Martin Dr. (11) (-) Leutz, Achim Prof. Dr. (1) (-) Wollert-Wulf, Brigitte (2) (-) Biologie maligner Lymphome (12) Genetik und Genomik von Herz- Kreislauferkrankungen (1) (-) Molekulare Zellbiologie und Gentherapie (1) Signaltransduktion in Tumorzellen (1) Signalvermittlung in Entwicklung und Krebsentstehung (1) Zelldifferenzierung und Tumorigenese (14) 2003 (3) (-) 2004 (2) (-) 2005 (3) (-) 2006 (4) 2007 (2) 2008 (2) (-) 2009 (3) 2010 (1) 2011 (4) 2012 (2) 2013 (2) 2014 (3) 2015 (2) 2016 (1) 2017 (3) 2018 (1) 2020 (4) 2021 (3) 2022 (6) 2023 (1) 12 Ergebnisse: Active Filter: Janz, Martin Dr.Leutz, Achim Prof. Dr.Wollert-Wulf, BrigitteBiologie maligner LymphomeMolekulare Zellbiologie und Gentherapie2004200520062009 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 29. Oktober 2009 in Blood C/EBPβ regulates transcription factors critical for proliferation and survival of multiple myeloma cells R. Pal M. Janz D.L. Galson M. Gries S. Li K. Johrens I. Anagnostopoulos B. Doerken M.Y. Mapara L. Borghesi L. Kardava G.D. Roodman C. Milcarek S. Lentzsch 01. September 2009 in Dtsch Med Wochenschr Die molekulare Pathogenese des klassischen Hodgkin-Lymphoms [The molecular pathogenesis of classical Hodgkin lymphoma] S. Mathas B. Doerken M. Janz 07. April 2009 in Proc Natl Acad Sci U S A Gene deregulation and spatial genome reorganization near breakpoints prior to formation of translocations in anaplastic large cell lymphoma S. Mathas S. Kreher K.J. Meaburn K. Joehrens B. Lamprecht C. Assaf W. Sterry M.E. Kadin M. Daibata S. Joos M. Hummel H. Stein M. Janz I. Anagnostopoulos E. Schrock T. Misteli B. Doerken 15. Mai 2006 in Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas 01. April 2006 in Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel 15. März 2006 in Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou 01. Februar 2006 in Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken 25. August 2005 in Blood Elevated NF-kappaB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large cell, and other peripheral T-cell lymphomas S. Mathas K. Joehrens S. Joos A. Lietz F. Hummel M. Janz F. Jundt I. Anagnostopoulos K. Bommert P. Lichter H. Stein C. Scheidereit B. Doerken 01. Januar 2005 in Blood Immunomodulatory derivative of thalidomide (IMiD CC-4047) induces a shift in lineage commitment by suppressing erythropoiesis and promoting myelopoiesis K.R. Koh M. Janz M.Y. Mapara B. Lemke D. Stirling B. Doerken M. Zenke S. Lentzsch 01. Januar 2005 in Blood A rapamycin derivative (everolimus) controls proliferation through down-regulation of truncated CCAAT enhancer binding protein beta and NF-kappaB activity in Hodgkin and anaplastic large cell lymphomas F. Jundt N. Raetzel C. Mueller C.F. Calkhoven K. Kley S. Mathas A. Lietz A. Leutz B. Doerken Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
29. Oktober 2009 in Blood C/EBPβ regulates transcription factors critical for proliferation and survival of multiple myeloma cells R. Pal M. Janz D.L. Galson M. Gries S. Li K. Johrens I. Anagnostopoulos B. Doerken M.Y. Mapara L. Borghesi L. Kardava G.D. Roodman C. Milcarek S. Lentzsch
01. September 2009 in Dtsch Med Wochenschr Die molekulare Pathogenese des klassischen Hodgkin-Lymphoms [The molecular pathogenesis of classical Hodgkin lymphoma] S. Mathas B. Doerken M. Janz
07. April 2009 in Proc Natl Acad Sci U S A Gene deregulation and spatial genome reorganization near breakpoints prior to formation of translocations in anaplastic large cell lymphoma S. Mathas S. Kreher K.J. Meaburn K. Joehrens B. Lamprecht C. Assaf W. Sterry M.E. Kadin M. Daibata S. Joos M. Hummel H. Stein M. Janz I. Anagnostopoulos E. Schrock T. Misteli B. Doerken
15. Mai 2006 in Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas
01. April 2006 in Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel
15. März 2006 in Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
01. Februar 2006 in Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
25. August 2005 in Blood Elevated NF-kappaB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large cell, and other peripheral T-cell lymphomas S. Mathas K. Joehrens S. Joos A. Lietz F. Hummel M. Janz F. Jundt I. Anagnostopoulos K. Bommert P. Lichter H. Stein C. Scheidereit B. Doerken
01. Januar 2005 in Blood Immunomodulatory derivative of thalidomide (IMiD CC-4047) induces a shift in lineage commitment by suppressing erythropoiesis and promoting myelopoiesis K.R. Koh M. Janz M.Y. Mapara B. Lemke D. Stirling B. Doerken M. Zenke S. Lentzsch
01. Januar 2005 in Blood A rapamycin derivative (everolimus) controls proliferation through down-regulation of truncated CCAAT enhancer binding protein beta and NF-kappaB activity in Hodgkin and anaplastic large cell lymphomas F. Jundt N. Raetzel C. Mueller C.F. Calkhoven K. Kley S. Mathas A. Lietz A. Leutz B. Doerken
